Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,752,620
+$273,735 QoQ
Shares Held
22,949
+14.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 99.00649265763214.ToString("F0")%
Shared 0.ToString("F0")%
None 0.9935073423678591.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BROWN ADVISORY INC holds $209,016,512 across 24 Biotechnology names. INSM ranks #5 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,451,048 | $75,831,766 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
133,953 | $44,321,027 | |
| 3 | CYTK |
Cytokinetics Inc
|
614,655 | $40,511,910 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
511,701 | $29,734,945 | |
| 5 | INSM |
INSMED Inc
This page
|
22,949 | $3,752,620 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,653 | $3,417,370 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,264 | $2,521,896 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
36,225 | $2,341,221 |
All Filings in INSM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,752,620 | 22,949 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,478,885 | 19,989 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,759,955 | 26,109 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $58,355,699 | 579,846 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $51,301,209 | 672,450 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $45,773,311 | 662,997 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||